Biden drug pricing plan seeks to balance access and innovation

13 September 2021 - On Thursday 9 September, Health and Human Services Secretary Xavier Becerra publicly released the Biden Administration’s ...

Read more →

Pharmaceutical companies should pay for raiding nature's medicine cabinet

11 August 2021 - In 2019, the pharmaceutical industry profited from US$1·2 trillion of global spending on medicines. Most of this ...

Read more →

Making pharmaceutical companies report what matters about innovation

29 July 2021 - There is a lack of transparency about the cost of innovation of the pharmaceutical industry even ...

Read more →

NHS England unveils new Innovative Medicine Fund

21 July 2021 - NHS England has unveiled its new Innovative Medicines Fund, to ensure patients have early access to ...

Read more →

Teplizumab awarded Innovation Passport in the United Kingdom for the delay of onset of clinical type 1 diabetes in at risk individuals

12 July 2021 - Designation is the first step in a new MHRA initiative to accelerate the development and access to ...

Read more →

Most Americans support Medicare negotiation despite claims it would hurt innovation

3 June 2021 - A new West Health/Gallup survey finds nearly all Democrats (97%) and the majority of Republicans (61%) support ...

Read more →

Making cancer treatments affordable today won’t hurt tomorrow’s innovation

12 May 2021 - Congress is about to debate legislation—the Lower Drug Costs Now Act (H.R.3)—that would give Medicare the ...

Read more →

New analysis shows international reference drug pricing would have a catastrophic impact on Alzheimer's disease research

22 April 2021 - Proposed policy would likely eliminate future clinical development programs in Alzheimer's research, impacting millions of patients and ...

Read more →

NICE launches ambitious strategy to provide quicker access to new treatments and innovations

19 April 2021 - NICE will transform key elements of its approach to ensure efficiency and speed while maintaining robust, trusted ...

Read more →

CBO report shows enacting drug pricing legislation will result in fewer new drugs

12 April 2021 - If there was a silver lining in the COVID-19 pandemic, it was the response of the biopharmaceutical ...

Read more →

NICE methods and process review aims to create fertile ground for innovation

29 March 2021 - The way NICE reviews new medicines is about to go through its biggest change in years – ...

Read more →

Taxpayers fund research and drug companies make a fortune

24 March 2021 - The pharmaceutical industry doesn’t want things to change, but Americans can have both lower prices and innovation. ...

Read more →

It’s time to fast track innovation in medical devices for children

11 February 2021 - When a baby arrived at Children’s National Hospital with a critically underdeveloped heart, it was clear ...

Read more →

Repurposing of prescription medicines

4 February 2021 - The Therapeutic Goods Administration is conducting a public consultation that seeks to understand potential obstacles and ...

Read more →

Funding of pharmaceutical innovation during and after the COVID-19 pandemic

14 January 2021 - The COVID-19 pandemic has highlighted the available mechanisms for funding research, development, manufacturing, and distribution in the ...

Read more →